Mount Sinai publishes 1st US guide for infection-linked chronic illnesses

SWAlexander

Senior Member
Messages
2,232
Excerpt:
New York City-based Mount Sinai Health System has released the country’s first clinical manual for treating infection-associated chronic illnesses, according to an Aug. 13 news release.

The clinical manual covers several infection-associated chronic illnesses, including long COVID, long Lyme disease, Ehlers-Danlos syndrome and myalgic encephalomyelitis/chronic fatigue syndrome.

Four hundred million people in the world have experienced long COVID, and millions more live with other infection-associated chronic illnesses, according to David Putrino, PhD, the Nash Family Director of the Cohen Center.
https://www.beckershospitalreview.c...guide-for-infection-linked-chronic-illnesses/
 

pamojja

Senior Member
Messages
2,834
Location
Austria
Important Medical Disclaimers ..............................................................................................4
Chapter 1 | Introduction ........................................................................................................5
About the Infection-Associated Chronic Illness (IACI) Manual ...........................................5
What Are IACIs? ...............................................................................................................7
Chapter 2 | Overview of IACIs...............................................................................................8
Mechanisms of Disease ....................................................................................................8
Multiple Hits.......................................................................................................................9
Common Misconceptions about IACIs............................................................................. 11
What Is Recovery? .......................................................................................................... 13
Chapter 3 | Current Research on the Drivers of IACIs ........................................................ 15
Drivers of Disease ........................................................................................................... 16
Persistence of Pathogens in Tissue ................................................................................ 17
Pathogen Reactivation Under Conditions of Immune Dysregulation ................................ 20
Mitochondrial Dysfunction ............................................................................................... 22
Coagulation & Vascular Dysfunction ............................................................................... 24
Dysautonomia & POTS ................................................................................................... 26
Neuroinflammation & Cognitive Dysfunction .................................................................... 28
Immune Activation, Dysfunction, & Autoimmunity............................................................ 30
Microbiome Imbalance & SIBO ....................................................................................... 31
Hormonal Imbalance ....................................................................................................... 33
Mast Cell Activation & Immune Cell Priming .................................................................... 34
Chapter 4 | Clinical Care Guidance ..................................................................................... 36
Environmental Design: Creating a Cultivated Patient Experience.................................... 37
Securing an Appointment at CoRE & the Onboarding Process ....................................... 39
Care Strategy at the CoRE .............................................................................................. 41
Follow-Up: Introduction to the Team Approach After the Initial Intake ............................. 44
In-Person Assessments at the CoRE .............................................................................. 46
Optional Research Opportunities..................................................................................... 47
Assessment Procedures & Treatment Recommendations Based on Clinical Findings .... 48
The Prevention of IACIs & When Reinfection Occurs ...................................................... 68
Chapter 5 | Allied Health Approaches to IACI Care ............................................................. 70
Psychology Services ....................................................................................................... 70
Social Work ..................................................................................................................... 72
Physical Therapy & Autonomic Rehabilitation ................................................................. 73
Nutritional Guidance ........................................................................................................ 75
Chapter 6 | At Home IACI Management Strategies ............................................................. 76
3
Pacing, Energy, & Assistive Technology in Complex Chronic Illness .............................. 76
Chapter 7 | Tick-Borne & Vector-Borne Illnesses ................................................................ 78
Overview of Tick-Borne & Vector-Borne Illnesses .............................................................. 78
Testing for Tick Borne & Vector-Borne Illnesses ............................................................. 80
Assessing & Treating Tick-Borne & Vector-Borne Illnesses ............................................ 81
Appendix A | Billing & Coding at the CoRE ......................................................................... 82
CoRE Assessment Order Sets & CPT Codes ................................................................. 82
Appendix B | Introduction Autonomic Rehabilitation ............................................................ 85
Autonomic Rehabilitation in Complex Chronic Illness ...................................................... 85
Spin Bike Upright Titration Protocol: A Symptom-Titrated Cardiovascular Training
Framework for Autonomic Rehabilitation ......................................................................... 93
Appendix C | Pacing, Energy, & Assistive Technology in Complex Chronic Illness ........... 104
Pacing, Energy, & Assistive Technology in Complex Chronic Illness ............................ 104
Mobility Aids .................................................................................................................. 110
Appendix D | Nutritional Guidance in Complex Chronic Illness ......................................... 113
Nutritional Guidance in Complex Chronic Illness ........................................................... 113
Appendix E | Introduction to Hypermobility Spectrum Disorders & Hypermobility Testing . 116
Hypermobility and Susceptibility in IACIs....................................................................... 116
Extracellular Matrix (ECM) Breakdown in hEDS & IACIs ............................................... 116
Neurologic Manifestations Associated with Hypermobility ............................................. 117
Subluxation & Dislocation Across the Body ................................................................... 121
Subluxation Reduction Guide for Hypermobility Disorders ............................................ 132
Proprioception Training in Hypermobility Rehabilitation ................................................. 136
Appendix F | Patient Reported Outcomes (PROs) ............................................................ 143
Appendix G | Blood Tests ................................................................................................. 160
Acknowledgements ........................................................................................................ 165
From Our CoRE Team ..................................................................................................... 165
Reviewers & Expert Contributors ..................................................................................... 166
 

BrightCandle

Senior Member
Messages
1,248
They sure do love exercise. They have dedicated 30+ pages to various exercises for progressing and improving symptoms. is David Putrino a Wessley fan? This document is no different to what the psychologists have been saying in the past decade, if you exercise below your PEM threshold you'll recover. Its nonsense of course but I am surprised to find David Putrino and Mount Sinai saying this.
 
Last edited:

pamojja

Senior Member
Messages
2,834
Location
Austria
@SWAlexander The pdf needs only a Mail, and filling out a short form for downloading.

They have dedicated 30+ pages to various exercises for progressing and improving symptoms. is David Putrino a Wessley fan?

Not at all. An excerpt:

MISCONCEPTION: Exercise is a safe, effective treatment for people with IACIs who are experiencing fatigue and post-exertional malaise
FACT: The original research supporting the use of graded exercise therapy for ME/CFS, and by extension Long COVID, is heavily flawed.
FACT: Many people with IACIs develop PEM. Dosing exercise incorrectly can lead to a worsening of symptoms within 48-72 hours. Pacing and rest are safer, effective alternatives.

The chapter of Physical Therapy & Autonomic Rehabilitation is not even 2 pages:

Autonomic dysfunction is a common, debilitating feature of IACIs, including Long
COVID, POTS, ME/CFS, and tick-borne disease. Symptoms like dizziness,
palpitations, blood pooling, and exercise intolerance reflect impaired regulation of
vascular tone and cardiac output—not simple deconditioning. Traditional exercise
protocols often fail these patients, and in some cases, worsen symptoms through
PEM.
Our approach to autonomic rehabilitation emphasizes symptom-guided pacing,
upright tolerance retraining, and gradual cardiovascular reconditioning. Patients
begin at their current level of positional tolerance (often supine) and progress
through phases that reintroduce upright positions, aerobic movement, and
neuromuscular control—always below the patient’s crash threshold.
Moving Beyond Graded Exercise Therapy (GET)
Rigid GET programs can cause harm in patients with PEM or dysautonomia.
Instead, we promote pacing and recovery-based progression using symptom-guided
thresholds (modified Borg RPE scale, VAS symptom tracking), positionally modified
exercises (e.g., supine to upright transition), adaptive breathwork to regulate
arousal and stabilize autonomic tone and therapist comfortability with small, even
active assisted movements when needed and progressing based on symptom
tolerance.
Foundation Protocols & Adaptations
Our team draws from established protocols (Dallas, CHOP-Modified Dallas, Levine)
and adapts them for infection-associated presentations. Early rehab often includes
recumbent cardio (e.g., spin bike with reclining chair in supine and progressing
through semi-reclined positions, recumbent and then upright bike and
standing on pedals), compression and fluid loading, low-load neuromuscular control in
gravity-minimized positions and vagal-supportive breathwork.
Breathwork as a Cornerstone
Breathing techniques improve parasympathetic tone, reduce orthostatic
symptoms, and support safe movement. Patients are trained in diaphragmatic,
pursed-lip, box, and VNS-based breathwork as part of every phase. These
tools not only stabilize physiology but also provide real-time feedback on readiness to
engage in activity. Progress isn’t linear. Patients may fluctuate between phase
74
Supporting Success
Autonomic rehabilitation is most effective when integrated with gentle
neuromuscular training for core and scapular stabilization, energy conservation
and pacing education, structured breathwork for readiness and recovery
(see more information in appendix), careful symptom tracking (e.g., RPE/VAS scales)
and flexible program design and language that honors each patient’s path.
Patients with connective tissue disorders (e.g., hEDS/HSD) require additional
stabilization strategies to protect joints and manage subluxation risk throughout
positional rehab.
We encourage providers to reference the Pacing and Hypermobile Rehabilitation
sections for additional considerations when treating these patients.
 
Last edited:

pamojja

Senior Member
Messages
2,834
Location
Austria
The main part about this paper is about the main mechanism of the diseases and their treatment.
Complex Chronic Illness Mechanisms of Disease

Pathogen persistence in tissue or host cells
Pathogen reactivation under conditions of immune dysregulation
Autonomic dysfunction
Coagulation issues and vascular dysfunction
Microbiome imbalance
Neuroinflammation and cognitive dysfunction
Mitochondrial dysfunction
Immune dysfunction and autoimmunity
Joint hypermobility
Mast cell activation
 

SWAlexander

Senior Member
Messages
2,232
I'm glad that the study mentioned on page 7:

"Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): For decades,
millions of individuals have also been diagnosed with ME/CFS, an IACI characterized
by severe fatigue, musculoskeletal pain, and PEM. Many cases of ME/CFS begin with
a viral infection or involve multiple exposures to viral and bacterial pathogens over
time. Pathogens most implicated in ME/CFS development include the herpesviruses
and enteroviruses."

I have read this publication back in 2020:

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity​

https://pubmed.ncbi.nlm.nih.gov/30564562/

There is a:

Symbiosis Between Viruses and Bacteria – A Fascinating Partnership in the Microbial World https://swaresearch.blogspot.com/2025/07/symbiosis-between-viruses-and-bacteria.html

 
Back